Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipopeptides from Bacillus atrophaeus MCM61 and melatonin suppress gray mold-induced oxidative stress in cut roses (Rosa hybrida L.) and improve vase life.
Malik J, Moosa A, Zulfiqar F, Althobaiti F, Andaleeb H, Alzamel NM, Alsharari SF, Fayad E, Al-Asmari F, Şimşek Ö, İzgü T, Tütüncü M, Al-Duais MA, Ghobashy MOI, Alwabsi HA, Zidan N, Sakran M, Soliman TMA. Malik J, et al. Among authors: tutuncu m. Curr Microbiol. 2024 Dec 3;82(1):28. doi: 10.1007/s00284-024-03987-0. Curr Microbiol. 2024. PMID: 39625681
Corrigendum to "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment" [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949].
Sen S, Tuncer A, Terzi M, Bunul SD, Ozen-Acar P, Altunrende B, Ozakbas S, Tutuncu M, Uygunoglu U, Akman-Demir G, Karabudak R, Efendi H, Siva A. Sen S, et al. Among authors: tutuncu m. Mult Scler Relat Disord. 2024 Dec;92:105917. doi: 10.1016/j.msard.2024.105917. Epub 2024 Oct 17. Mult Scler Relat Disord. 2024. PMID: 39423726 No abstract available.
Employment, work hours, and wages in adults with myelin oligodendrocyte glycoprotein antibody disease: An international cohort study.
Ham AS, Gomez Hjerthen I, Sudhir A, Pandit L, Reddy YM, Murthy JM, Tian DC, Gu H, Gao W, Broadley SA, Leitner U, Aw AYY, Tan K, Yeo T, Reyes S, Toro J, Gaitán J, Ramírez DA, Comme-Debroth R, Báez JPM, Gulec B, Uygunoglu U, Tutuncu M, Siva A, Iorio R, Sabatelli E, Huda S, Kelly P, Rojas JI, Cristiano E, Patrucco L, Oliveira EML, Portugal RP, Zaidan PPT, Viswanathan S, Koh K, Lim SY, Mateen FJ. Ham AS, et al. Among authors: tutuncu m. Mult Scler. 2024 Nov;30(13):1674-1682. doi: 10.1177/13524585241286671. Epub 2024 Oct 11. Mult Scler. 2024. PMID: 39392718
Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis.
Zeydan B, Azevedo CJ, Makhani N, Cohen M, Tutuncu M, Thouvenot E, Siva A, Okuda DT, Kantarci OH, Lebrun-Frenay C. Zeydan B, et al. Among authors: tutuncu m. CNS Drugs. 2024 Dec;38(12):973-983. doi: 10.1007/s40263-024-01117-9. Epub 2024 Sep 16. CNS Drugs. 2024. PMID: 39285136 Review.
90 results